Neurogene Inc. · NASDAQ:NGNE
Redmile Group, LLC reported a 9.90% stake in Neurogene Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Redmile Group, LLC reported a 9.90% stake in Neurogene Inc., 1,572,202 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 9.90%
- Shares
- 1,572,202
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Redmile Group, LLC | 9.90% | 1,572,202 |
| Jeremy C. Green | 9.90% | 1,572,202 |
| Redmile Biopharma Investments I, L.P. | 5.10% | 812,033 |
Source
Related
- Neurogene Inc.
- Redmile Group, LLC
- Neurogene Inc. shareholders
- Schedule 13G/A · Redmile Group, LLC · Feb 17, 2026
- Schedule 13G/A · Redmile Group, LLC · Feb 14, 2025
- Schedule 13G · Prudential Financial Inc · Oct 7, 2026
- Schedule 13G · Jennison Associates LLC · Oct 6, 2026
- Form 4 · McMinn Rachel · Oct 2, 2026
- Schedule 13G · Balyasny Asset Management L.P. · Aug 14, 2026
- Schedule 13G/A · Trails Edge Capital Partners, LP · Aug 14, 2026